Soquelitinb, A selective inhibitor of interleukin-2-inducible kinase (ITK), is active in several murine models of T cell-mediated inflammatory disease
L.-Y. Hsu, J. T. Rosenbaum, S. Lindner…·R. A. Miller
This study shows that soquelitinib inhibits ITK and reduces T cell-mediated inflammation in multiple murine models.